These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 7673422

  • 1. Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.
    Newman CB, Melmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, Stewart WN, Klibanski A, Molitch ME, Gagel RF.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2768-75. PubMed ID: 7673422
    [Abstract] [Full Text] [Related]

  • 2. Octreotide as primary therapy for acromegaly.
    Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL.
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [Abstract] [Full Text] [Related]

  • 3. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ, Plöckinger U.
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.
    Ho KY, Weissberger AJ, Marbach P, Lazarus L.
    Ann Intern Med; 1990 Feb 01; 112(3):173-81. PubMed ID: 2404445
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group.
    Vance ML, Harris AG.
    Arch Intern Med; 1991 Aug 01; 151(8):1573-8. PubMed ID: 1872661
    [Abstract] [Full Text] [Related]

  • 6. Effective clinical response to long term octreotide treatment, with reduced serum concentrations of growth hormone, insulin-like growth factor-I, and the amino-terminal propeptide of type III procollagen in acromegaly.
    Salmela PI, Juustila H, Pyhtinen J, Jokinen K, Alavaikko M, Ruokonen A.
    J Clin Endocrinol Metab; 1990 Apr 01; 70(4):1193-201. PubMed ID: 2180976
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Octreotide treatment of acromegaly. A randomized, multicenter study.
    Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, Molitch ME, Boyd AE, Sheeler L, Cook DM.
    Ann Intern Med; 1992 Nov 01; 117(9):711-8. PubMed ID: 1416572
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group.
    Giusti M, Gussoni G, Cuttica CM, Giordano G.
    J Clin Endocrinol Metab; 1996 Jun 01; 81(6):2089-97. PubMed ID: 8964833
    [Abstract] [Full Text] [Related]

  • 10. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS, Musolino NR, Salgado LR, Bronstein MD.
    Clin Endocrinol (Oxf); 2005 Aug 01; 63(2):168-75. PubMed ID: 16060910
    [Abstract] [Full Text] [Related]

  • 11. A prospective multicenter octreotide dose response study in the treatment of acromegaly.
    Ezzat S, Redelmeier DA, Gnehm M, Harris AG.
    J Endocrinol Invest; 1995 May 01; 18(5):364-9. PubMed ID: 7594225
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Octreotide long term treatment of acromegaly: effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values.
    Plöckinger U, Liehr RM, Quabbe HJ.
    J Clin Endocrinol Metab; 1993 Jul 01; 77(1):157-62. PubMed ID: 8325938
    [Abstract] [Full Text] [Related]

  • 14. Time course of GH and IGF-1 levels following withdrawal of long-acting octreotide in acromegaly.
    Lorcy Y, Dejager S, Chanson P, French Octreotide LAR Group.
    Pituitary; 2000 Nov 01; 3(3):193-7. PubMed ID: 11383486
    [Abstract] [Full Text] [Related]

  • 15. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA, McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA, Wardlaw JM.
    J Clin Endocrinol Metab; 2002 Oct 01; 87(10):4554-63. PubMed ID: 12364434
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
    Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G.
    J Clin Endocrinol Metab; 2001 Jun 01; 86(6):2779-86. PubMed ID: 11397887
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide.
    Page MD, Millward ME, Taylor A, Preece M, Hourihan M, Hall R, Scanlon MF.
    Q J Med; 1990 Feb 01; 74(274):189-201. PubMed ID: 2111918
    [Abstract] [Full Text] [Related]

  • 18. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
    Jenkins PJ, Emery M, Howling SJ, Evanson J, Besser GM, Monson JP.
    Horm Res; 2004 Feb 01; 62(5):227-32. PubMed ID: 15477693
    [Abstract] [Full Text] [Related]

  • 19. Four years' treatment of resistant acromegaly with octreotide.
    McKnight JA, McCance DR, Sheridan B, Atkinson AB.
    Eur J Endocrinol; 1995 Apr 01; 132(4):429-32. PubMed ID: 7711880
    [Abstract] [Full Text] [Related]

  • 20. Medical management of acromegaly--what and when?
    Melmed S.
    Acta Endocrinol (Copenh); 1993 Jul 01; 129 Suppl 1():13-7. PubMed ID: 8372605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.